We are live on ! Find out more
WMSA

Weiss Multi-Strategy Advisers Portfolio holdings

AUM $4.16B
1-Year Est. Return 30.77%
This Fund
S&P 500
This Quarter Est. Return
-2.79%
1 Year Est. Return
+30.77%
3 Year Est. Return
+78.91%
5 Year Est. Return
+263.81%
10 Year Est. Return
+424.97%
AUM
$4.09B
AUM Growth
-$502M
Cap. Flow
-$407M
Cap. Flow %
-9.94%
Top 10 Hldgs %
30.55%
Holding
883
New
176
Increased
142
Reduced
142
Closed
370

Top Buys

Rank Stock Value
1
EGN
Energen
EGN
+$29.1M
2
C icon
Citigroup
C
+$28.9M
3
CCEP icon
Coca-Cola Europacific Partners
CCEP
+$27.4M
4
PKY
Parkway, Inc.
PKY
+$24.6M
5
NRG icon
NRG Energy
NRG
+$23.4M

Sector Composition

Rank Sector Weight
1 Financials 11.83%
2 Energy 9.56%
3 Real Estate 7.25%
4 Consumer Staples 5.69%
5 Healthcare 5.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SDRL
401
PUT
DELISTED
Seadrill Limited Common Stock
SDRL
$803K 0.02%
+112
New +$1.06M
AFFX
402
DELISTED
Affymetrix Inc
AFFX
$798K 0.02%
100,000
KEX icon
403
Kirby Corp
KEX
$7.95B
$794K 0.02%
6,736
ITCI
404
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$794K 0.02%
57,945
SGNT
405
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
$778K 0.02%
25,000
-40,000
-62% -$1.08M
CSLT
406
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$776K 0.02%
60,000
+25,497
+74% +$336K
XOMA
407
DELISTED
Xoma
XOMA
$758K 0.02%
9,000
SDRL
408
DELISTED
Seadrill Limited Common Stock
SDRL
$749K 0.02%
105
+30
+40% +$284K
INCY icon
409
CALL
Incyte
INCY
$23.5B
$736K 0.02%
15,000
+900
+6% +$45.1K
ESPR
410
DELISTED
Esperion Therapeutics
ESPR
$734K 0.02%
30,000
ARRY
411
DELISTED
Array Biopharma Inc
ARRY
$732K 0.02%
205,000
+20,000
+11% +$78.8K
AKRX
412
DELISTED
Akorn Inc
AKRX
$725K 0.02%
20,000
-2,230
-10% -$79.9K
SXE
413
DELISTED
Southcross Energy Partners, L.P.
SXE
$719K 0.02%
+33,674
New +$761K
PBR icon
414
Petrobras
PBR
$121B
$710K 0.02%
+50,000
New +$837K
ANW
415
DELISTED
Aegean Marine Petroleum Network
ANW
$705K 0.02%
76,831
+7,356
+11% +$72.2K
EVHC
416
DELISTED
Envision Healthcare Holdings Inc
EVHC
$694K 0.02%
6,680
-6,680
-50% -$709K
VCYT icon
417
Veracyte
VCYT
$4.52B
$683K 0.02%
70,000
QGENF
418
DELISTED
QIAGEN NV
QGENF
$683K 0.02%
30,000
CLVS
419
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
$680K 0.02%
+15,000
New +$627K
VNDA icon
420
Vanda Pharmaceuticals
VNDA
$312M
$675K 0.02%
65,000
-10,000
-13% -$131K
HUM icon
421
Humana
HUM
$46.7B
$651K 0.02%
+5,000
New +$635K
NUWE icon
422
Nuwellis
NUWE
$189K
0
CCEC
423
Capital Clean Energy Carriers
CCEC
$1.4B
$649K 0.02%
+9,286
New +$701K
UTHR icon
424
CALL
United Therapeutics
UTHR
$26.3B
$643K 0.02%
+5,000
New +$515K
HSTO
425
DELISTED
Histogen Inc. Common Stock
HSTO
$643K 0.02%
525

Similar funds

Weiss Multi-Strategy Advisers's Q3 2014 Portfolio in Review

As of Q3 2014, Weiss Multi-Strategy Advisers held 883 positions worth $4.09B, down 11% from $4.6B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Weiss Multi-Strategy Advisers withdrew a net $407M in Q3 2014, closing 370 positions and reducing 142 holdings. Its most notable exit was Lamar Advertising Co, an estimated $37.1M position sold in full.

By sector, the portfolio is most concentrated in Financials at 12% of assets, up from 9.4% a quarter earlier, followed by Energy and Real Estate.

Against the trend, Weiss Multi-Strategy Advisers opened a new position in Energen worth $26.3M.

  • Weiss Multi-Strategy Advisers's largest Q3 2014 buy was Energen: 363,900 shares worth $26.3M.
  • Weiss Multi-Strategy Advisers added most to Coca-Cola in Q3 2014, an estimated $22.4M increase.
  • Weiss Multi-Strategy Advisers's biggest Q3 2014 reduction was Fifth Third Bancorp, cutting an estimated $30.8M.
  • Weiss Multi-Strategy Advisers fully exited Lamar Advertising Co in Q3 2014, selling an estimated $37.1M.
  • Weiss Multi-Strategy Advisers's ten largest holdings make up 31% of its $4.09B portfolio in Q3 2014.
  • Weiss Multi-Strategy Advisers opened 176 new positions and closed 370 in Q3 2014.
  • Weiss Multi-Strategy Advisers's portfolio value fell 11% quarter-over-quarter to $4.09B.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q3 2014, filed 14 Nov 2014.